FILING DEADLINE–Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of BMRN, …

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

CEDARHURST, N.Y., Oct. 13, 2020 (GLOBE NEWSWIRE) — The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of the following publicly traded companies.

BioMarin Pharmaceutical Inc. (BMRN)
Class Period: February 28, 2020 and August 18, 2020
Lead Plaintiff Motion Deadline: November 24, 2020
SECURITIES FRAUD
To learn more, visit https://kclasslaw.com/cases/securities/nasdaqgs-bmrn/

Peabody Energy Corp. (BTU)
Class Period: April 3, 2017 and October 28, 2019
Lead Plaintiff Motion Deadline: November 27, 2020
SECURITIES FRAUD
To learn more, visit https://kclasslaw.com/cases/securities/nyse-btu/

Credit Acceptance Corporation (CACC)
Class Period: November 1, 2019 and August 28, 2020
Lead Plaintiff Motion Deadline: December 1, 2020
SECURITIES FRAUD
To learn more, visit https://kclasslaw.com/cases/securities/nasdaqgs-cacc/

Shareholders who purchased shares in these companies during the dates listed are encouraged to contact us via the case links above,

Read More

DEADLINE ALERT for FENC, POR, HDB, and UPLCQ: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders .

 The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.

Investors suffering losses on their investments are encouraged to contact The Law Offices of Frank R. Cruz to discuss their legal rights in these class actions at 310-914-5007 or by email to [email protected]

Fennec Pharmaceuticals Inc.
Class Period: February 11, 2020 – August 10, 2020
Lead Plaintiff Deadline: November 2, 2020

The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors: (1) that the manufacturing facilities for PEDMARK, the Company’s sole product candidate, did not comply with current

Read More

DEADLINE ALERT for HDB, UPLCQ, LX, YAYO: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders.

 Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.

Investors suffering losses on their investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in these class actions at 888-638-4847 or by email to [email protected]

HDFC Bank Limited 
Class Period: July 31, 2019 – July 10, 2020
Lead Plaintiff Deadline: November 2, 2020

The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) HDFC Bank had inadequate disclosure controls and procedures and internal control over financial reporting; (2) as a

Read More

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Peabody Energy Corporation (BTU) Investors

LOS ANGELES, Oct. 9, 2020 /PRNewswire/ — The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired Peabody Energy Corporation (“Peabody” or the “Company”) (NYSE: BTU) common stock between April 3, 2017 and October 28, 2019, inclusive (the “Class Period”).  Peabody investors have until November 27, 2020to file a lead plaintiff motion.

If you are a shareholder who suffered a loss, click here to participate.

On September 28, 2018, Peabody announced that it did “not expect any production from North Goonyella in the fourth quarter of 2018” due to a fire occurring within the mine.

On this news, the Company’s stock price fell $5.54, or over 13%, to close at $35.64 per share on September 28, 2018, thereby injuring investors.

Then, on February 6, 2019,

Read More

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Nikola Corporation (NKLA) Investors

LOS ANGELES, Oct. 8, 2020 /PRNewswire/ — The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired Nikola Corporation f/k/a VectoIQ Acquisition Corp. (“Nikola” or “VectoIQ” or the “Company”) (NASDAQ: NKLA) securities between March 3, 2020 and September 15, 2020, inclusive (the “Class Period”). Nikola investors have until November 16, 2020to file a lead plaintiff motion.

If you are a shareholder who suffered a loss, click here to participate.

On September 10, 2020, Hindenburg Research published a report entitled “Nikola: How to Parlay an Ocean of Lies into a Partnership with the Largest Auto OEM in America.” Therein, Hindenburg alleged that the Company’s founder, Trevor Milton, had misled partners into signing agreements by falsely claiming to have extensive proprietary technology. Among other things, the report claimed that Milton

Read More

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of NextCure, Inc. (NXTC) Investors

LOS ANGELES, Oct. 6, 2020 /PRNewswire/ — The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired NextCure, Inc. (“NextCure” or the “Company”) (NASDAQ: NXTC): (a) securities between November 5, 2019 and July 14, 2020, inclusive (the “Class Period”); and/or (b) common stock pursuant or traceable to the Company’s November 2019 secondary public offering (“SPO” or the “Offering”). NextCure investors have until November 20, 2020 to file a lead plaintiff motion.

If you are a shareholder who suffered a loss, click here to participate.

In November 2019, NextCure completed its SPO, selling over 4 million shares at $36.75 per share.

On January 13, 2020, NextCure disclosed that Eli Lilly and Company had ended its collaboration agreement for the research and development of the Company’s leading product candidate, NC318, a

Read More